Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.

Loss of heterozygosity (LOH) at the long arm of chromosome 16 occurs in at least half of all breast tumors and is considered to target one or more tumor suppressor genes. Despite extensive studies by us and by others, a clear consensus of the boundaries of the smallest region of overlap (SRO) could not be identified. To find more solid evidence for SROs, we tested a large series of 712 breast tumors for LOH at 16q using a dense map of polymorphic markers. Strict criteria for LOH and retention were applied, and results that did not meet these criteria were excluded from the analysis. We compared LOH results obtained from samples with different DNA isolation methods, ie., from microdissected tissue versus total tissue blocks. In the latter group, 16% of the cases were excluded because of noninterpretable LOH results. The selection of polymorphic markers is clearly influencing the LOH pattern because a chromosomal region seems more frequently involved in LOH when many markers from this region are used. The LOH detection method, i.e., radioactive versus fluorescence detection, has no marked effect on the results. Increasing the threshold window for retention of heterozygosity resulted in significantly more cases with complex LOH, i.e., several alternating regions of loss and retention, than seen in tumors with a small window for retention. Tumors with complex LOH do not provide evidence for clear-cut SROs that are repeatedly found in other samples. On disregarding these complex cases, we could identify three different SROs, two at band 16q24.3 and one at 16q22.1. In all three tumor series, we found cases with single LOH regions that designated the distal region at 16q24.3 and the region at 16q22.1. Comparing histological data on these tumors did not result in the identification of a particular subtype with LOH at 16q or a specific region involved in LOH. Only the rare mucinous tumors had no 16q LOH at all. Furthermore, a positive estrogen content is prevalent in tumors with 16q LOH, but not in tumors with LOH at 16q24.3 only.

[1]  G. Fleuren,et al.  PCR artifacts in LOH and MSI analysis of microdissected tumor cells. , 2000, Human pathology.

[2]  R. Richards,et al.  Chromosomal fragile site FRA16D and DNA instability in cancer. , 2000, Cancer research.

[3]  C. Keck,et al.  Identification of a YAC from 16q24 carrying a senescence gene for breast cancer cells , 2000, Oncogene.

[4]  J. Peterse,et al.  Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type , 1999, British Journal of Cancer.

[5]  A. Cleton-Jansen,et al.  Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3. , 1999, Genomics.

[6]  R. Athwal,et al.  Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells , 1999, Oncogene.

[7]  S. Hirohashi,et al.  Correlation of numerical and structural status of chromosome 16 with histological type and grade of non‐invasive and invasive breast carcinomas , 1999, International journal of cancer.

[8]  A. Cleton-Jansen,et al.  Genomic structure and expression analysis of the spastic paraplegia gene, SPG7 , 1999, Human Genetics.

[9]  A. Hanby,et al.  Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. , 1999, Cancer research.

[10]  C. Poremba,et al.  Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathways , 1999, The Journal of pathology.

[11]  C. Mathew,et al.  The PISSLRE gene: structure, exon skipping, and exclusion as tumor suppressor in breast cancer. , 1999, Genomics.

[12]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[13]  A D Auerbach,et al.  Characterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancer. , 1998, Genomics.

[14]  I. Petersen,et al.  Chromosome alterations in breast carcinomas: frequent involvement of DNA losses including chromosomes 4q and 21q. , 1998, British Journal of Cancer.

[15]  M A Newton,et al.  On the statistical analysis of allelic-loss data. , 1998, Statistics in medicine.

[16]  G. Bevilacqua,et al.  A region on the long arm of chromosome 16 is frequently deleted in metastatic node-negative breast cancer. , 1998, International journal of oncology.

[17]  J. Overgaard,et al.  Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. , 1998, Cancer research.

[18]  C. Mathew,et al.  Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer. , 1998, Genomics.

[19]  Y. Ishikawa,et al.  Identification of a 910‐Kb region of common allelic loss in chromosome bands 16q24.1–q24.2 in human lung cancer , 1998, Genes, chromosomes & cancer.

[20]  J Isola,et al.  Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.

[21]  L. Jeng,et al.  Frequent allelic loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in Taiwan. , 1998, Cancer letters.

[22]  T. Godfrey,et al.  Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma. , 1997, Cancer genetics and cytogenetics.

[23]  F. Baas,et al.  Allelotype of pediatric rhabdomyosarcoma , 1997, Oncogene.

[24]  R. Lidereau,et al.  Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. , 1997, Genes, chromosomes & cancer.

[25]  A. Sahin,et al.  Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. , 1996, Cancer research.

[26]  M. Emi,et al.  Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers , 1996, Genes, chromosomes & cancer.

[27]  G. Berx,et al.  E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. , 1996, Oncogene.

[28]  M. Vijver,et al.  E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.

[29]  I. Hostein,et al.  Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers , 1995, Genes, chromosomes & cancer.

[30]  S. Hilsenbeck,et al.  Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. , 1995, The American journal of pathology.

[31]  N. Phillips,et al.  Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. , 1995, Cancer research.

[32]  M. Stratton,et al.  Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. , 1995, Journal of clinical pathology.

[33]  R. Barkardottir,et al.  High frequency of allelic imbalance at chromosome region 16q22‐23 in human breast cancer: Correlation with high pgr and low s phase , 1995, International journal of cancer.

[34]  C. Croce,et al.  Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. , 1995, Cancer research.

[35]  M. James,et al.  Allelotype of head and neck paragangliomas: Allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL , 1994, Genes, chromosomes & cancer.

[36]  P. Devilee,et al.  At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer , 1994, Genes, chromosomes & cancer.

[37]  Y. Nakamura,et al.  Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. , 1994, Cancer research.

[38]  M. Hultén,et al.  Chromosomes 1 and 16 in sporadic breast cancer. , 1993, Genes, Chromosomes and Cancer.

[39]  C. Larsson,et al.  Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. , 1993, Cancer research.

[40]  D. Pinkel,et al.  Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors , 1992 .

[41]  F. Mitelman,et al.  Whole‐arm t(1;16) and i(1q) as sole anomalies identify gain of 1 q as a primary chromosomal abnormality in breast cancer , 1992, Genes, chromosomes & cancer.

[42]  R. Stallings,et al.  High-resolution cytogenetic-based physical map of human chromosome 16. , 1992, Genomics.

[43]  R. Richards,et al.  Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. , 1992, Genomics.

[44]  P L Pearson,et al.  Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. , 1991, Oncogene.

[45]  O. Garson,et al.  Cytogenetic features of twenty-six primary breast cancers. , 1991, Cancer genetics and cytogenetics.

[46]  B. Dutrillaux,et al.  Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. , 1990, Cancer genetics and cytogenetics.

[47]  I. Ellis,et al.  Pathology and breast screening , 1990, Histopathology.

[48]  J. Weber,et al.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. , 1989, American journal of human genetics.

[49]  Cornelisse Cj,et al.  Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement. , 1984 .

[50]  A. Cleton-Jansen,et al.  Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes. , 1997, British Journal of Cancer.

[51]  Å. Borg,et al.  Loss of heterozygosity at 7q31 in breast cancer: results from an International Collaborative Study Group. The Breast Cancer Somatic Genetics Consortium. , 1997, Genes, chromosomes & cancer.

[52]  ©1999 Cancer Research Campaign Article no. bjoc.1998.0168 Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3 , 2022 .